The nonprofit, Baltimore-based Lieber Institute for Brain Development, an affiliate of Johns Hopkins University School of Medicine, is partnering with Astellas, Eli Lilly ($LLY), Lundbeck, Pfizer ($PFE) and Roche ($RHHBY) to launch an early-stage research consortium to study the genetic mechanisms at work in brain disorders. Researchers will analyze RNA, the genomic and epigenetic data obtained from human brains, with the goal of identifying new treatment options for patients. Release